Study

EORTC-2324-QLG-TCG

Long-term quality of life and late toxicity in thyroid cancer survivors (LoQoT)

Study documentation Back to result

Trial Status

Recruiting

Dates

Date of activation: 01-Nov-2025

Data management at EORTC

None

Design

QoL Non Module Study Development
Not randomized / N.A.

Targeted Sample size

EORTC Groups: 2320 - All Groups: 2320

Treatment

None

Study Staff

  • Laura Locati (Study Coordinator), Istituti Clinici Scientifici Maugeri, Pavia
  • Susanne Singer (Study Coordinator), Univ. Rostock - Campus Schilingallee, Rostock
  • Lotte van der Weijst (QoL Specialist), EORTC Headquarters, Brussels

Type of cancer

  • Thyroid

Participating groups

  • EORTC Quality of Life Group
  • EORTC Thyroid Cancer Group